Isaacs, D.J., Kathuria-Prakash, N., Hilder, R., Lechner, M.G. and Drakaki, A. 2024. Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy. Current Cancer Reports. 5, 1 (Jan. 2024), 168-180. DOI:https://doi.org/10.25082/CCR.2023.01.004.